Risk Management


<< Back
Share
 Print

OMIC Digest Archives 2022

OMIC Digest: Vol. 32 | No. 1 | 2022

  • Feature: Giant Cell Arteritis: Delayed diagnosis and treatment
  • Eye on OMIC: Board changes and a new Chair announced for 2023
  • Policy Issues: Liability and coverage for patient falls
  • Closed Claim Study: Failure to diagnose Giant Cell Arteritis results in settlement
  • Risk Management Remedies: What’s in your toolbox?
  • < click to view or download
 

 
Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Leave a comment



Six reasons OMIC is the best choice for ophthalmologists in America.

Best at defending claims.

An ophthalmologist pays nearly half a million dollars in premiums over the course of a career. Premium paid is directly related to a carrier’s claims experience. OMIC has a higher win rate taking tough cases to trial, full consent to settle (no hammer) clause, and access to the best experts. OMIC pays 25% less per claim than other carriers. As a result, OMIC has consistently maintained lower base rates than multispecialty carriers in the U.S.

61864684